Construct · 1 fields · 1 citations

HER2-low breast cancer: a standalone construct

One name. One construct. A landmark on the map.

● anchor · a standalone construct Nearest construct by meaning·not indexed

A single standalone construct; nearby constructs are located against it in the Collider. Tap a field for its definition, unit, and measures.

Oncology

breast cancer with immunohistochemistry HER2 score of 1+ or 2+ without gene amplification, described as a distinct group between HER2-negative and HER2-positive.

In oncology, HER2-low breast cancer refers to breast cancer with immunohistochemistry HER2 score of 1+ or 2+ without gene amplification, described as a distinct group between HER2-negative and HER2-positive. This meaning comes from Tarantino (2020) in Journal of Clinical Oncology.[1]

Unit
Recovery means
Measured by

Run it through the Collider, or take the citations with you.

See how HER2-low breast cancer sits against neighbouring constructs in the Collider, or export every reference on this page in one click.

Open in Collider Export BibTeX Report this entry

Nearby constructs

amplification4 fields · 4 citationsjingle · one word, four constructs group4 fields · 4 citationsjingle · one word, four constructs score2 fields · 3 citationsjingle · one word, two constructs

References

Tarantino, P., Hamilton, E., Tolaney, S. M., Cortes, J., Morganti, S., Ferraro, E., Marra, A., Viale, G., Trapani, D., Cardoso, F., Penault-Llorca, F., Viale, G., Andrè, F., & Curigliano, G. (2020). HER2-Low Breast Cancer: Pathological and Clinical Landscape. Journal of Clinical Oncology, 38(17), 1951-1962. https://doi.org/10.1200/jco.19.02488

Cited on this page?

Confirm your construct, or correct us.

If your work is cited behind one of these entries, you know better than we do whether we captured the meaning right. Confirm it, suggest an edit, or dispute it, and your name goes on the entry as an author who has checked it, linked to your ORCID.

Claim your construct